Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Nature Communications|July 15, 2023
Impact of TMB/PD-L1 expression and pneumonitis on chemoradiation and durvalumab response in stage III NSCLCJoao V Alessi, Biagio Ricciuti, Xinan Wang, et al.
JCO Precision Oncology|May 14, 2026
Multimodal Impact of Number of Metastases and Genetic Alterations on Survival in Metastatic Non-Small Cell Lung CancerN Ari Wijetunga, Nikhil P Mankuzhy, Emily S Lebow, et al.
International Journal of Radiation Oncology, Biology, Physics|July 2, 2026
Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution SeriesLauren Linkowski, Ian Messing, Melanie Berger, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2023
Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with AlectinibEmily Miao, Jordan E Eichholz, Emily S Lebow, et al.
Journal for Immunotherapy of Cancer|November 1, 2023
Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancerJoao V Alessi, Adam Price, Allison L Richards, et al.
Practical Radiation Oncology|July 28, 2022
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice GuidelineLia M Halasz, Albert Attia, Lisa Bradfield, et al.
The Oncologist|February 15, 2026
Outcomes after SRS and Ipilimumab plus Nivolumab for Melanoma Brain Metastases Following Prior Immune Checkpoint Inhibitor or Targeted TherapyIan Messing, Lauren Linkowski, Matthew D Riina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2026
Durvalumab With Radiation Therapy in Patients With Inoperable Locally Advanced Non-Small Cell Lung Cancer Ineligible for Concurrent Chemoradiotherapy (DART)Andreas Rimner, Emily S Lebow, Kelly J Fitzgerald, et al.
JCO Precision Oncology|September 4, 2024
Early Circulating Tumor DNA Shedding Kinetics for Prediction of Platinum Sensitivity in Patients With Small Cell Lung CancerYonina R Murciano-Goroff, Angela B-Y Hui, Jose A Araujo Filho, et al.
Lung Cancer (Amsterdam, Netherlands)|July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusionsSebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Pageof 3